The diagnostic performance in clinically significant prostate cancer with PI-RADS version 2.1: simplified bpMRI versus standard mpMRI

被引：0
|
作者：
Jihui Song
Chenglin Zhao
Fei Zhang
Yingdi Yuan
Lee M. Wang
Vivek Sah
Jun Zhang
Wencai Weng
Zhenghan Yang
Zhenchang Wang
Liang Wang
机构：
[1] Beijing Friendship Hospital,Department of Radiology
[2] Capital Medical University,Department of Radiology
[3] Dalian University Affiliated Xinhua Hospital,Department of Radiology
[4] QUFU City People Hospital,Department of Radiology
[5] Ganzhou District People’s Hospital,Department of Radiology
[6] Carnegie Mellon University,undefined
[7] ADK Hospital,undefined
[8] The First Hospital of Qinhuangdao,undefined
来源：
Abdominal Radiology | 2023年 / 48卷
关键词：
PI-RADS; Prostate cancer; Screening; Simplified biparametric MRI; Multiparametric MRI; Abbreviated protocol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：704 / 712
页数：8
相关论文
共 50 条
  • [21] A nomogram based on PI-RADS v2.1 and clinical indicators for predicting clinically significant prostate cancer in the transition zone
    Wei, Chaogang
    Pan, Peng
    Chen, Tong
    Zhang, Yueyue
    Dai, Guangcheng
    Tu, Jian
    Jiang, Zhen
    Zhao, Wenlu
    Shen, Junkang
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (06) : 2435 - 2446
  • [22] PI-RADS upgrading as the strongest predictor for the presence of clinically significant prostate cancer in patients with initial PI-RADS-3 lesions
    Kwe, Jeremy
    Baunacke, Martin
    Boehm, Katharina
    Platzek, Ivan
    Thomas, Christian
    Borkowetz, Angelika
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [23] Considering Predictive Factors in the Diagnosis of Clinically Significant Prostate Cancer in Patients with PI-RADS 3 Lesions
    Natale, Caleb
    Koller, Christopher R.
    Greenberg, Jacob W.
    Pincus, Joshua
    Krane, Louis S.
    LIFE-BASEL, 2021, 11 (12):
  • [24] Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results
    Thomas Auer
    Michael Edlinger
    Jasmin Bektic
    Udo Nagele
    Thomas Herrmann
    Georg Schäfer
    Friedrich Aigner
    Daniel Junker
    World Journal of Urology, 2017, 35 : 687 - 693
  • [25] Performance of PI-RADS version 1 versus version 2 regarding the relation with histopathological results
    Auer, Thomas
    Edlinger, Michael
    Bektic, Jasmin
    Nagele, Udo
    Herrmann, Thomas
    Schaefer, Georg
    Aigner, Friedrich
    Junker, Daniel
    WORLD JOURNAL OF UROLOGY, 2017, 35 (05) : 687 - 693
  • [26] Assessment of PI-RADS v2 categories ≥ 3 for diagnosis of clinically significant prostate cancer
    Nayana U. Patel
    Kimberly E. Lind
    Kavita Garg
    David Crawford
    Priya N. Werahera
    Sajal S. Pokharel
    Abdominal Radiology, 2019, 44 : 705 - 712
  • [27] Index lesion detection in multifocal prostate cancer: Simplified PI-RADS biparametric MRI vs PI-RADS v2.1 multiparametric MRI
    Scialpi, Michele
    Martorana, Eugenio
    Torre, Riccardo
    Scalera, Giovanni Battista
    Belatti, Eugenio
    Improta, Antonio
    Aisa, Maria Cristina
    Burani, Aldo
    Santini, Nicola
    D'Andrea, Alfredo
    Mancioli, Francesco Maria
    Scialpi, Pietro
    Di Blasi, Aldo
    CLINICAL IMAGING, 2023, 94 : 108 - 115
  • [28] Prospective PI-RADS v2.1 Atypical Benign Prostatic Hyperplasia Nodules With Marked Restricted Diffusion: Detection of Clinically Significant Prostate Cancer on Multiparametric MRI
    Costa, Daniel N.
    Jia, Liwei
    Subramanian, Naveen
    Xi, Yin
    Rofsky, Neil M.
    Recchimuzzi, Debora Z.
    de Leon, Alberto Diaz
    Arraj, Patrick
    Pedrosa, Ivan
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2021, 217 (02) : 395 - 402
  • [29] Exploration of the diagnostic capacity of PSAMR combined with PI-RADS scoring for clinically significant prostate cancer and establishment and validation of the Nomogram prediction model
    Dengke Li
    Lulu Zhang
    Yujie Xu
    Xun Wu
    Shaokui Hua
    Yan Jiang
    Qunlian Huang
    Yukui Gao
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 11309 - 11317
  • [30] Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer
    Stevens, Erica
    Truong, Mathew
    Bullen, Jennifer A.
    Ward, Ryan D.
    Purysko, Andrei S.
    Klein, Eric A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (11) : 846.e9 - 846.e16
12345